Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-59
SponsorThe Netherlands Cancer Institute
About this trial
This study is a prospective, multicenter study in which a serum sample will be collected at the day of starting neo adjuvant treatment in breast cancer patients
Eligibility criteria
Qualifiers
Women with a new diagnosis of triple negative breast cancer who have not yet started systemic treatment.
Patients with stage I-III disease, patient with locoregional recurrence who have not been treated with chemotherapy before. ,
Aged < 60 years
Women having a (regular) physiological menstrual cycle
Disqualifiers
Oral contraception (OAC)
Hormonal intra-uterine device (IUD, Mirena)
No ovarian function suppression to preserve fertility
Other forms of hormonal contraception, including but not limited to: nuva-ring, Implanon, prikpil
Trial design
Treatments tested in this trial
- Blood sample
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov